View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Nicolas David
  • Nicolas David

Nemetschek SE : Nemetschek rolls out its strategy and has another good...

>Solid Q1 2024 lends credence to 2024 guidance - Nemetschek reported Q1 2024 results on Tuesday morning. Sales grew by 10.3% at cc to € 223.9m and the EBITDA margin came to 30.5%. These results allowed the group to confirm 2024 guidance for: i/ sales growth of 10-11% at cc; ii/ EBITDA margin of 30-31%; and iii/ a share of recurring revenues of around 85%. In the conference call, management made several comments about the trajectory of results in 2024. The increase i...

Maissa Keskes ... (+2)
  • Maissa Keskes
  • Stephane Houri

Siltronic AG : Better-than-expected Q1 2024 results, FY 2024 outlook r...

>Strong Q1 24 results - This morning, Siltronic reported its Q1 2024 results which were above expectations. Revenues were € 343.5m, 1% above the consensus at € 340m. They were down 4% q-o-q and down 15% y-o-y. While the wafer area sold and sales prices remained nearly stable compared to the previous quarter, the product mix had a slightly negative impact. The gross margin was 20.4% above with consensus at 14.4%. The operating results was € 36m, giving a margin of 10....

Nicolas David
  • Nicolas David

Nemetschek SE : Nemetschek déroule sa stratégie et réalise un nouveau ...

>Le T1 2024 solide crédibilise les guidances pour 2024 - Nemetschek a publié mardi matin ses résultats T1 2024. Le chiffre d'affaires était en hausse de 10,3% à cc (à 223.9 M€) et la marge d’EBITDA s’est établie à 30,5%. Ces résultats ont permis au groupe de confirmer sa guidance 2024, à savoir : i/ une croissance du chiffre d’affaires entre 10% et 11% à cc ; ii/ une marge d’EBITDA entre 30% et 31% ; et iii/ une part de revenus récurrents d’environ 85%. Au cours de la...

 PRESS RELEASE

EQS-News: Ergebnis der Siltronic AG im ersten Quartal 2024 wie erwarte...

EQS-News: Siltronic AG / Schlagwort(e): Quartalsergebnis/Quartals-/Zwischenmitteilung Ergebnis der Siltronic AG im ersten Quartal 2024 wie erwartet weiterhin geprägt von Nachfrageschwäche aufgrund erhöhter Kundenbestände 02.05.2024 / 07:01 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Pressemitteilung Siltronic AG Einsteinstraße 172 81677 München   Ergebnis der Siltronic AG im ersten Quartal 2024 wie erwartet weiterhin geprägt von Nachfrageschwäche aufgrund erhöhter Kundenbestände - Umsatz gegenüber Vorquartal vor allem aufgr...

 PRESS RELEASE

EQS-News: As expected, Siltronic's Q1 2024 earnings continue to be imp...

EQS-News: Siltronic AG / Key word(s): Quarter Results/Quarterly / Interim Statement As expected, Siltronic's Q1 2024 earnings continue to be impacted by weak demand due to elevated customer inventories 02.05.2024 / 07:01 CET/CEST The issuer is solely responsible for the content of this announcement. Press release Siltronic AG Einsteinstraße 172 81677 Munich   As expected, Siltronic's Q1 2024 earnings continue to be impacted by weak demand due to elevated customer inventories - Sales compared to the previous quarter decreased by 3.7 percent to EUR 343.5 million, mainly...

 PRESS RELEASE

ROCKWOOL A/S – transactions in connection with share buy-back programm...

ROCKWOOL A/S – transactions in connection with share buy-back programme Company announcementfor ROCKWOOL A/SRelease no. 20 – 2024to Nasdaq Copenhagen         1 May 2024 ROCKWOOL A/S – transactions in connection with share buy-back programme As mentioned in announcement no. 02/2024, ROCKWOOL A/S has initiated a share buy-back programme which will run from 8 February 2024 until 7 February 2025. During this period, the Company will buy own shares for up to a maximum of 160 MEUR. The programme is implemented in accordance with EU Commission Regulation No 596/2014 of 16 April 2014 and EU Com...

Wedbush Research
  • Wedbush Research
2454 MEDIATEK INC.
LOGN LOGITECH INTERNATIONAL S.A.
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SBUX STARBUCKS CORPORATION
RWT REDWOOD TRUST INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PCRX PACIRA BIOSCIENCES INC.
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MCD MCDONALD'S CORPORATION
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FTNT FORTINET INC.
FATE FATE THERAPEUTICS INC
EXLS EXLSERVICE HOLDINGS INC.
EAT BRINKER INTERNATIONAL INC.
DENN DENNY'S CORPORATION
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ARDX ARDELYX INC
SWKS SKYWORKS SOLUTIONS INC.
FRX_CN FENNEC PHARMACEUTICALS
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
TMHC TAYLOR MORRISON HOME CORPORATION
HPE HEWLETT PACKARD ENTERPRISE CO.
TWTR TWITTER INC.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
HEAR TURTLE BEACH CORP.
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
PINS PINTEREST INC. CLASS A
BCEL ATRECA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
LC LENDINGCLUB CORP
SMCI SUPER MICRO COMPUTER
AQST INC.
IDYA AQUESTIVE THERAPEUTICS
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
CRSR ADICET BIO INC
ITOS CORSAIR GAMING
ZNTL ITEOS THERAPEUTICS
PRAX ZENTALIS PHARMACEUTICALS
FUBO PRAXIS PRECISION MEDICINES
TVTX FUBOTV
LSEA TRAVERE THERAPEUTICS INC
VRDN LANDSEA HOMES CORP (A)
DAWN VIRIDIAN THERAPEUTICS INC
ELEV DAY ONE BIOPHARMACEUTICALS INC
OMGA ELEVATION ONCOLOGY
LBPH OMEGA THERAPEUTICS
THRX LONGBOARD PHARMACEUTICALS
MRVL THESEUS PHARMACEUTICALS
STX INC.
DSGN MARVELL TECHNOLOGY INC
ATXS SEAGATE TECHNOLOGY HLDGS PLC
AVTE DESIGN THERAPEUTICS INC
GFS ASTRIA THERAPEUTICS INC
RLYB AEROVATE THERAPEUTICS INC
KRTX GLOBALFOUNDRIES INC
FUSN RALLYBIO CORP
VIGL KARUNA THERAPEUTICS INC
EWTX FUSION PHARMACEUTICALS INC
VIGIL NEUROSCIENCE INC
EDGEWISE THERAPEUTICS INC
 PRESS RELEASE

Galapagos’ shareholders adopt all resolutions proposed by the Board of...

Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024 Mechelen, Belgium; 30 April 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announces that all resolutions proposed at the company’s Annual and Extraordinary Shareholders’ Meetings (AGM and EGM) held on 30 April 2024 were approved. The AGM approved, amongst other items: The Remuneration Report and revised Remuneration PolicyThe remuneration of the members of the Board of DirectorsThe reappointment of Dr. Elisabeth Svanberg as Independent...

 PRESS RELEASE

Galapagos’ aandeelhouders keuren alle door de Raad van Bestuur voorges...

Galapagos’ aandeelhouders keuren alle door de Raad van Bestuur voorgestelde besluiten goed op de jaarlijkse Gewone en Buitengewone Algemene Aandeelhoudersvergaderingen 2024 Mechelen, België; 30 april 2024; 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) maakt vandaag bekend dat alle voorstellen tot besluit op de jaarlijkse Gewone en Buitengewone Algemene Aandeelhoudersvergaderingen van 30 april 2024 zijn goedgekeurd. De jaarlijkse Gewone Algemene Aandeelhoudersvergadering keurde onder meer goed: Het Remuneratieverslag en gewijzigde RemuneratiebeleidDe bezoldiging van de BestuurdersDe he...

Alicia Reese ... (+3)
  • Alicia Reese
  • Brandon Barron
  • Michael Pachter
Michael B. Schäfer
  • Michael B. Schäfer

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 04/30/2024

BHP's bid for Anglo American has confirmed interest from miners in copper in the context of increasingly challenged production and difficulties in fully completing projects. Anglo’s (Neutral) prospects in copper are now better valued and this is also the case for BHP (Neutral vs Underperform) although not so for Rio Tinto (Outperform vs Neutral). Downstream, Nexans and Montana Aerospace are our Top Picks (Outperform) vs Aurubis, Rexel and Prysmian (Neutral). - ...

Michael B. Schäfer
  • Michael B. Schäfer

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 30/04/2024

L’offre de BHP sur Anglo American a confirmé l’intérêt des minières pour le cuivre dans un contexte de tensions croissantes sur la production et de difficultés à faire aboutir les projets. Les perspectives d’Anglo (Neutre) dans le cuivre sont désormais mieux valorisées, c’est aussi le cas de BHP (Neutre vs Sous-performance) mais pas encore assez, selon nous, sur Rio Tinto (Surperformance vs Neutre). En aval, Nexans et Montana Aerospace sont nos valeurs préférées (Surperformance) vs Au...

Nicolas David
  • Nicolas David

Nemetschek SE : Good Q1 24 results with a top line 1% above and an in-...

>Q1 2024 results slightly above expectations for revenue - Nemetschek released this morning its Q1 2024 release. ARR came out at € 743.6m, up by 24.5% y-o-y and 25.4% at cc (vs ODDO BHF: € 751.2m). Total revenue stands at € 223.9m, up 9.4% on a reported basis and 10.3% at cc, which was 1% above expectations (ODDO BHF: € 222.2m, 9.7% at cc / Visible Alpha css: € 222.5m, 9.4% at cc). The group’s revenue was again driven by subscription and SaaS models which increased b...

Nicolas David
  • Nicolas David

Nemetschek SE : Good Q1 24 results with a top line 1% above and an in-...

>Q1 2024 results slightly above expectations for revenue - Nemetschek released this morning its Q1 2024 release. ARR came out at € 743.6m, up by 24.5% y-o-y and 25.4% at cc (vs ODDO BHF: € 751.2m). Total revenue stands at € 223.9m, up 9.4% on a reported basis and 10.3% at cc, which was 1% above expectations (ODDO BHF: € 222.2m, 9.7% at cc / Visible Alpha css: € 222.5m, 9.4% at cc). The group’s revenue was again driven by subscription and SaaS models which increased b...

Paul Charpentier
  • Paul Charpentier

Nemetschek - SaaS momentum accelerates in Q1 2024

Nemetschek delivered solid growth in Q1 2024, with a homogenous contribution from every division. The quarter was marked by the acceleration of SaaS and subscription revenue (+68% Y/Y) and a confirmation of both short term and long-term growth objectives (+10-11% in FY2024e and >+15% in FY2025e)

Alicia Reese ... (+3)
  • Alicia Reese
  • Brandon Barron
  • Michael Pachter
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch